Rapid Antigen tests advised only for symptomatic people, immediate contacts of Covid positive patients: ICMR

New Delhi : The Indian Council of Medical Research (ICMR) on Wednesday said that only symptomatic individuals and immediate contacts of Covid-19 positive patients are advised for home testing by Rapid Antigen Tests (RAT).

“Home testing by RAT is advised only in symptomatic individuals and immediate contacts of laboratory-confirmed positive cases. Indiscriminate testing is not advised. Home testing should be conducted as per the procedure described by the manufacturer in the user manual (pictorial and video link of the user manual is provided below against the name of the approved test kit),” reads the ICMR advisory.

ICMR suggests users to download the home testing mobile app on their smartphones and said the app is a comprehensive guide of the testing procedure and will provide a positive or negative test result to the patient.

“All users are advised to click a picture of the test strip after completing the test procedure with the same mobile phone which has been used for downloading the mobile app and user registration. Data in the app of your mobile phone will be centrally captured in a secure server that is connected with the ICMR Covid-19 testing portal, where all data will be eventually stored. Patient confidentiality will be fully maintained. All individuals who test positive may be considered as true positives and no-repeat testing is required,” ICMR said.

The Council further said symptomatic individuals who test negative by RAT should get themselves immediately tested by RTPCR. “This is especially important as the RATs are likely to miss few positive cases presenting with a low viral load. All RAT negative symptomatic individuals may be treated as suspect Covid-19 cases,” it added.

ICMR informed CoviSelf (PathoCatch) Covid-19 OTC Antigen LF device manufactured by Pune-based Mylab Discovery Solutions Ltd has been validated and approved. (ANI)

  • Related Posts

    • Pharma
    • June 19, 2025
    • 85 views
    Pharma stock jumps after receiving approval from UK’s MHRA to sell new pharma product

    This small-cap pharma stock, engaged in the research, manufacturing, and marketing of generic pharmaceutical formulations across global markets, rose over 2% in today’s trade after receiving approval for its product…

    • Pharma
    • June 19, 2025
    • 119 views
    HIV prevention drug hailed as a ‘breakthrough’ gets FDA approval

    A drug with the potential to drastically curb the HIV epidemic just cleared its first regulatory hurdle. On Wednesday, the Food and Drug Administration approved lenacapavir for the prevention of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Pharma stock jumps after receiving approval from UK’s MHRA to sell new pharma product

    Pharma stock jumps after receiving approval from UK’s MHRA to sell new pharma product

    HIV prevention drug hailed as a ‘breakthrough’ gets FDA approval

    HIV prevention drug hailed as a ‘breakthrough’ gets FDA approval

    ED raids three pharma units in Baddi, Nalagarh

    ED raids three pharma units in Baddi, Nalagarh

    Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

    Glenmark Pharma: FDA concludes inspection at US facility, issues five observations